ABP Stock Summary and Trading Ideas (Abpro Hldgs | NASDAQ:ABP)

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Abpro Hldgs trades on the NASDAQ stock market under the symbol ABP.

As of December 5, 2025, ABP stock price declined to $5.81 with 26,238 million shares trading.

ABP has a beta of 1.55, meaning it tends to be more sensitive to market movements. ABP has a correlation of 0.02 to the broad based SPY ETF.

ABP has a market cap of $15.78 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that ABP belongs to (by Net Assets): VXF.

ABP has underperformed the market in the last year with a price return of -87.5% while the SPY ETF gained +14.2%. ABP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.9% and -17.5%, respectively, while the SPY returned +6.2% and +4.0%, respectively.

ABP support price is $5.91 and resistance is $6.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABP shares will trade within this expected range on the day.